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ABSTRACT
The School of Graduate Studies
The University of Alabama in Huntsville

Degree: Doctor of Nursing Practice
Name of Candidate:
Title:

College: Nursing

Carey Haugen

__Peer Mentoring: Improving Health Outcomes in Dialysis Patients__
The lifestyle changes which accompany dialysis may be overwhelming for

patients and their carers. The objective of this project was to adapt and implement a
predesigned peer mentor program; to evaluate the effects of a peer mentor program on the
quality of life (QOL), depression symptoms, and self-efficacy of the program
participants; and to compare the effects with a comparison group. A two-armed, mixedmethod, pre/post-intervention evaluation method was used to conduct this project. Data
was collected from the Aurora Dialysis rural outpatient dialysis center. A predesigned
peer mentor program was adapted and implemented. Participants, adult individuals with
kidney disease that required dialysis, were selectred through convenience sampling
method as a mentor, mentee, or comparison. The participants completed phone
interactions, provided social support, shared lived experiences, and dialysis related selfcare. Six mentors, six mentees, and 11 comparison participants completed the project. A
paired samples t-test showed no statistically significant differences in self-efficacy,
depression symptoms, nor QOL for mentors or mentees. The Anova test showed no
statistically significant differences between the mentors and mentees with the comparison
group. Feedback from 100% of mentors and 60% of mentees indicated high satisfaction
and recommended the peer mentor program continue. Nursing support of the peer
mentor program includes recruitment of appropriate mentors and answering clinical
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questions to promote success and sustainability of the program. Peer mentoring has
potential to provide non-hierarchial support and to cross cultural barriers. Additional
research is needed to support health realted outcomes and peer mentoring in individuals
requiring dialysis.

5

ACKNOWLEDGMENTS
I would like to acknowledge the contribution of Aurora Dialysis and all the individuals
on hemodialysis for their participation. Thank you to Dr. Amiri, faculty chair, for all of
her assistance and recommendations. I would also like to acknowledge Dr. Karen
Semmens for her assistance and support of this project.

6

TABLE OF CONTENTS
Page
SECTION I: DNP PROJECT
I. Identification of the Problem………………………………………………….....10
II. Review of the Evidence………………………………………………….………13
III. Conceptual Framework………………………………….........……………….…17
IV. Implementation of Peer Mentor Quality Improvement Plan…………………….20
V. Evaluation of Objectives………….…………………………………………...…30
SECTION II: DNP PROJECT PRODUCT
I. Professional Journal Selection………………………………………….......…32
A. Scope of Journal………………………………………………………32
B. Aims of Journal……………………………………………………....32
II. Title of Manuscript……………………………………………………………33
A. Identification of the Problem………………………………………...37
B. Conceptual Framework………………………………………………40
C. Methods…………………………………………………….………...44
D. Results………………………………………………………………..50
E. Discussion…………………………………………………………....53
F. Lessons Learned……………………………………………….……..56
References………………………………………………………………………………..61
Table1 …………………………………………………………………..……………….71
Table 2 ……………………………………………….……………….…………………72
Table 3 ……………………………………………………………….………………….73

7

Table 4 ………………………………………………………………………..…………74
Table 5 ………………………………………..…………..……………………………..75
Table 6 …………………………………………..……………..………………………..76
Figure 1 ………………………….…………………………..………………………..…77
Figure 2 …………………………………………………….……………………………78
Figure 3 …………………………………………………………..……………………..79
Appendices


IRB Approval



Facility Approval Letter



Informed Consent Statement



Permission Email



Staff Training Material



Recruitment Script



Peer Mentor Program Application



Mentor Guide



Mentor Log



Mentee Log



Mentor Feedback Form



Mentee Feedback Form



SEMCD



KDQOL-36



PHQ-9



Author Guidelines

8

Peer Mentoring: Improving Health Outcomes in Dialysis Patients
The development and progression of chronic kidney disease (CKD) is a major
health concern. The Centers for Disease Control and Prevention (CDC) reports chronic
disease remains the leading cause of “death and disability in the United States (US)” and
nearly half of all adults have at least one chronic disease (2015). Currently, over 30
million Americans have CKD (CDC, 2015). Progression of CKD results in end-stage
renal disease (ESRD). The National Institute of Health (NIH, 2016) defines ESRD as
permanent kidney failure, which requires renal replacement therapy or kidney transplant.
The incident of ESRD continues to rise since 2011 with 124,000 new cases annually with
99% over the age of 22 years (United States Renal Data System [USRDS], 2017). The
prevalence of ESRD rises 20,000 cases annually (USRDS, 2017).
In 2015 there were over 700,000 cases of ESRD in the US (USRDS, 2017). In
the US, with over 468,000 individuals (National Kidney Foundation, 2016), dialysis is
the most common type of renal replacement therapy (USRDS, 2017). ESRD and
dialysis place a substantial financial burden on society. Medicare spending for ESRD
patients exceeded $30.9 billion in 2013, which is 7.1% of all Medicare claims (NIH,
2016). Dialysis patients are older and have more comorbidities than years past which
compounds the health and financial issues surrounding ESRD and dialysis (Gilpin &
Nichols, 2010; Perry et al., 2005).
The increasing incidence and prevalence rates of dialysis pose unique issues to
nursing. This large patient population needs care, compassion, and education to selfmanage their chronic disease. Most ESRD patients also have comorbid chronic health
conditions of hypertension and diabetes (USRDS, 2017). Many physical and emotional
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life changes, including social and psychological challenges, accompany a diagnosis of
ESRD with required dialysis or transplant (Morton, Tong, Howard, Snelling, & Webster,
2010; Shell, Patel, Ammarell, & Steinhauser, 2012; Tong et al., 2009). The use of
available resources is necessary to promote positive health outcomes in this population.
The purpose of this Doctor of Nursing Practice (DNP) project was to implement an
adapted predesigned peer mentor quality improvement project and evaluate health
outcomes in dialysis patients.
Identification of the Problem
The progression to ESRD requiring dialysis may be overwhelming for patients
and their carers. Dialysis is a life-changing treatment plan requiring changes in lifestyle
(Jankowska-Polanksa et al., 2016; Kaitelidou et al., 2005) and limits the ability to be
gainfully employed which significantly impacts the patient, patient’s family, and society
(Ghahramani, 2015). In addition to significant morbidity and mortality (Ghahramani,
2015), dialysis often results in physical disability and depression (Finkelstein &
Finkelstein, 2000; Kimmel, Weihs, & Peterson, 1993; Theofilou, 2011). Additional
symptoms faced by patients on dialysis include decreased social relationships, sleep
disturbances, and anxiety (Jankowska-Polanska et al., 2016; Theofilou, 2011). The
symptoms experienced by dialysis patients result in an overall decreased quality of life
when compared to healthy individuals (Jankowska-Polanska et al., 2016).
The complex nature of chronic disease management requires support and input
from a variety of sources (Embuldeniya et al., 2013). Trained healthcare professionals,
such as nurses, often provide dialysis patients with information and education on
symptom management (Bennett, St. Clair Russell, Atwal, Brown, & Schiller, 2018).
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Dialysis patients require education on self-management of fluid intake, dietary
restrictions, and medication schedules (as stated in St. Clair Russell et al., 2017). This
education is often complex and is delivered at a time of high anxiety for patients
transitioning to dialysis (St. Clair Russell et al., 2017). Nurses, although trained
healthcare professionals, may not fully comprehend the challenges faced by dialysis
patients as they have not experienced these challenges personally (Tim, King, & Bennett,
2007).
Reduction of Disease Burden
A reduction in the kidney disease burden is beneficial for both patients and health
care organizations. One goal of Healthy People 2020 is to decrease the incidence and
prevalence of CKD and its complications (Office of Disease Prevention and Health
Promotion, 2016). Utilizing available resources to reduce complications and kidney
disease burden is essential to improving patient outcomes while providing safe and
quality care. Efforts to engage patients and their families within the resources of
healthcare systems has become an interest of national concern. Quality improvement
(QI) initiatives involving patient engagement, such as the peer mentor program, are
recommended by Centers for Medicare and Medicaid Services (CMS, 2018), Institute for
Healthcare Improvement (IHI, 2018), World Health Organization (WHO, 2018), and the
Midwest Kidney Network (2018). Peer mentoring in dialysis patients has been shown to
reduce disease burden and improve health outcomes in dialysis patients (Bennett et al.,
2018; Collins, 2016; Feroze et al., 2010; Ghahramani, 2015; Parry & Watt-Watson, 2009;
St. Clair Russell, et al., 2017; Symister & Friend, 2003; Thong, Kaptein, Krediet,
Boeschoten, & Dekker, 2007).
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Peer Mentor Program
The peer mentor program pairs a patient who has previously experienced or is
currently experiencing ESRD and hemodialysis (mentor) with a dialysis patient (mentee)
to develop a personal relationship which provides emotional support and information on
common health-related issues (Dennis, 2003; Hughes, Wood, & Smith, 2009). Newly
diagnosed ESRD patients requiring hemodialysis and patients struggling to self-manage
their condition may benefit from peer support through a peer mentor program (Taylor,
Gutteridge, & Willis, 2016).
Strengths of the peer mentor program include health related benefits to both
mentor and mentee (Bennett et al., 2018; Collins, 2016) such as improved survival and
quality of life in dialysis patients (Thong et al., 2007). Weaknesses of the program
include the amount of time and cost needed to train mentors, limited clinical research and
some mentees reported increased anxiety while participating in the peer mentor program
(Hughes et al., 2009).
PICOT Question
The PICOT question of interest was, in outpatient adult hemodialysis patients,
how will a peer mentor program affect the quality of life, depression symptoms, and selfefficacy in program participants compared to non-program participants over three
months?
Objectives
1- To adapt and implement a predesigned peer mentor program in one outpatient
hemodialysis facility
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2- To evaluate the effects of a peer mentor program on quality of life of program
participants
3- To evaluate the effects of a peer mentor program on depression symptoms of the
program participants.
4- To evaluate the effects of a peer mentor program on the self-efficacy of the
program participants.
5- To compare the effects of a peer mentor program on quality of life, depression
symptoms, and self-efficacy with a comparison group (no peer mentor program).
Tools used to evaluate these objectives included the Kidney Disease Quality of
Life (Rand Health, 2018), Patient Health Questionnaire (Pfizer, 1999), and Self-Efficacy
for Managing Chronic Disease surveys (Self-Management Resource Center, 2018).
These objectives were evaluated within the peer mentor program participants and
between the participants (intervention) and non-participants (comparison group).
Process objectives. The process objectives included enrolling 16 participants in
the intervention and 16 participants in the comparison group; completing this QI project
including development, implementation, and data collection within six months; and
evaluation of a minimum of eight mentor/mentee interactions within the three-month peer
mentor program.
Review of the Evidence
Search Criteria Process
A comprehensive search strategy for peer mentoring was completed. The
following electronic databases were searched from 1983 to 2019: CINAHL, Cochrane
Library, Medscape, and PubMed. Inclusion filter criteria included peer-reviewed,
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English language, and academic journals. MeSH search terms included: “peer mentor”
and “peer support” combined with “end-stage renal disease,” “dialysis,” “kidney
disease,” and “chronic disease”. Using the search terms “peer support + chronic disease”
provided the best initial results. Using these search terms in CINAHL yielded 120
results. Initial review of articles included only articles about individual peer mentor
programs excluding peer group support yielded 20 articles. Repeating the process in
Cochrane Library, Medscape, and PubMed yielded an additional two articles. Full review
of these 22 articles including references for each article yielded an additional six articles
for a total of 28 articles pertaining to the PICOT question.
Literature Review Themes
Peer mentoring affects outcomes. Peer mentoring promotes positive outcomes
by offering personalized patient-centered support (Ghahramani, 2015) from a trained peer
in a real, authentic, and non-hierarchical manner (Bennett et al., 2018). Healthcare staff
from four facilities incorporated peer mentoring in primary care practices reported that
the roles of the peer mentor include aiding in daily symptom management, social and
emotional support, linking clinical care and community resources, and providing ongoing
support (Mayer et al., 2016). Peer mentor program participants report perceptions of the
program include feeling a sense of connection, experiential knowledge, finding meaning
in one’s life, decreased isolation, reciprocity, helping, and role satisfaction (Embuldeniya
et al., 2013) and understanding, empathy, coping, hope, and adaption to demanding
treatment regimens (Hughes et al., 2009). Peer mentor programs are effective models in
increasing end-of-life planning for dialysis patients (Perry et al., 2003; Perry et al., 2005)
and choice of treatment modality (Ghahramani et al., 2015; Morton et al., 2010).
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Peer mentoring has also been shown to be a useful model in promoting positive
health outcomes for both mentor and mentee. Program participants demonstrated an
increase in disease management knowledge, self-efficacy, and social support (Feroze et
al., 2010; St. Clair Russell, et al., 2017; Symister & Friend, 2003). The National Kidney
Foundation’s peer mentoring program has reported increased patient activation measure
(PAM) which reflects increased readiness in patients to self-manage kidney disease
symptoms (Collins, 2016). Improved quality of life has been associated with mentee
participation in the peer mentor program (St. Clair Russell et al., 2017; Thong et al.,
2007). These positive patient outcomes have been associated with increased survival
(Thong et al., 2007).
Components of the peer mentor program. Key peer mentor program
components may be applied flexibly depending on the aim of the program and the needs
of the healthcare system and population (Bennett et al., 2018; Boothroyd & Fisher, 2010).
Key program components have been identified to include assistance in disease
management skills, emotional and social support, linkage to clinical care, and ongoing
support (Boothrod & Fisher, 2010; Fisher et al., 2014). Disease management skills and
support may be included as components of mentor training. Linkage to clinical care and
ongoing support may be included as components of staff training.
Method of program delivery must be flexible to meet the needs of the population;
however, consistent enough to promote positive patient outcomes (Fisher et al., 2014).
Offering a variety of meeting options increases the likelihood of meeting individual
patient personality preferences (Fisher et al., 2014). The most prevalent programs offer a
combination of face-to-face and telephone combination (Bennett et al., 2018). Face-to-
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face meetings and telephone calls have been shown to eliminate distance barriers and
facilitate diverse methods of contact (Bennett et al., 2018). An initial face-to-face
meeting may provide immediate reassurance and support for the mentee, while ongoing
monthly telephone calls assist in the development of the mentor-mentee relationship
(Bennett et al., 2018).
The length of peer mentor programs is also dependent on program objectives.
Extended period programs promote the development of strong personal relationships
(Heisler, 2006; Perry et al., 2005). Shorter programs, which do not have objectives to
develop strong personal relationships, offer targeted interactions with bidirectional
sharing of experiences and support, which has been shown to promote positive outcomes
in the ESRD population (Taylor et al., 2016). Positive patient outcomes have been
associated with peer mentor programs lasting a minimum of eight weeks with mixed
methods of program delivery (Joseph, Griffin, Hall, & Sullivan, 2001; MacPherson,
Joseph, & Sullivan, 2004; St. Clair Russell, 2017; Sutton & Erlen, 2006).
Training is critical to the success of the program. Mentor and staff training are
important aspects of a successful peer mentor program. Comprehensive mentor training
is necessary to prepare the mentor to facilitate the support of a mentee without providing
medical advice (Bennett et al., 2018). Key components of mentor training include
communication skills training (Bennett et al., 2018; Collins, 2016; Funnell, 2010; Perry et
al., 2003; Radice, 1995), problem solving (Bennett et al., 2018; Collins, 2016; Perry et
al., 2003), confidentiality (Bennett et al., 2018; Collins, 2016; Radice, 199), disease
knowledge for self-management of symptoms (Bennett et al., 2018; Boothroyd & Fisher,
2010; Fisher et al., 2015; Perry et al., 2003; Radice, 1995), and methods of providing
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social and emotional support (Boothroyd & Fisher, 2010; Collins, 2016; Fisher et al.,
2015; Funnell, 2010).
Staff training is necessary to provide support to the mentor/mentee team and for a
successful program (Bennett et al., 2018; McCarthy, 2017). An interdisciplinary program
team provides oversight and support for the program (Boothroyd & Fisher, 2010; Fisher
et al., 2015; Fisher et al., 2014), provides mentor backup to answer clinical questions as
needed (Fisher et al., 2014), and recruiting mentors/mentees (Bennett et al., 2018). The
supportive staff promotes program success and sustainability (Bennett et al., 2018). A
Masters’ level social worker (MSW) has advanced education to perform the functions of
the program coordinator, matching a mentor with a mentee, mentor training, and program
management (Brown, 2006).
Conceptual Framework
The conceptual framework used to design this DNP project was the self-efficacy
theory. Bandura’s (1977) theory of self-efficacy indicates a person’s self-belief in the
competencies one possesses will increase or decrease the chance of successfully
accomplishing a task. The ability to engage with one’s environment is more than
knowing what to do in a situation (Bandura, 1982). Efficacy with successful interactions
in the environment involves a mixture of behavior, social, and cognitive skills (Bandura,
1982).
People try to maintain control of their lives by controlling events. Perceived selfefficacy is a belief in one’s ability to adapt to changes in an environment that may be
ambiguous, unpredictable, and stressful (Bandura, 1986; Bandura, 1997). The theory of
self-efficacy is not indicated to measure a person’s adaptation skills but is intended to
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measure a perceived belief of what a person thinks can be accomplished with the skill set
already possessed (Bandura, 1986). A person’s most profound fear is defenselessness or
total loss of control of their personal environment (Bandura, 1986).
The development of new skills and expansion of current skills generates human
stress (Wiedenfeld et al., 1990). Stress contributes to physical dysfunctions, such as
immunologic suppression (Wiedenfeld et al., 1990) and decreases quality of life (Ames,
Jones, Howe, & Brantley, 2001). Perceived self-efficacy affects the directions and
magnitude of stress on the body by the process of coping (Wiedenfeld et al., 1990). This
involves the process of appraising one’s coping efficacy in the face of unremitting
stressors (Widenfeld et al., 1990). A person’s ability to cope with changing events and
social conditions may significantly affect feelings of futility, despondency, and anxiety
(Bandura, 1982). A person may give up if overwhelmed by these negative feelings
(Bandura, 1982). Development of strong self-efficacy is needed to change feelings of
futility, despondency, depression, and anxiety (Bandura, 1982). A person with strongly
perceived self-efficacy is more likely to persist until they are successful in accomplishing
the task at hand and can overcome negative feelings (Bandura, 1982). Self-efficacy
provides the intrinsic motivation that may cultivate competence (Bandura & Schunk,
1981), which may lead to improved quality of life in dialysis patients.
Increasing perceived self-efficacy involves four sources of information: mastery
experiences, vicarious experiences, verbal persuasion, and physiological states (Bandura,
1977). These sources of information are incorporated in varying degrees to increase
self-efficacy and decrease stressors (Bandura, 1977).
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Mastery experiences. Mastery experiences are associated with the most
substantial increase in self-efficacy (Bandura, Adams, & Bever, 1997). Repeated
successful task completion increases perceived self-efficacy while repeated failures lower
perceived self-efficacy (Bandura, 1977; Bandura, 1982). High self-efficacy from
successful personal experience mastery reduces the negative impact of occasional failures
(Bandura, 1977). Induction of mastery experiences self-efficacy includes participant
modeling, performance desensitization, performance exposure, and self-instructed
performance (Bandura, 1977).
Vicarious experiences. Vicarious experiences are the second most powerful
source of self-efficacy (Bandura, Adams, & Bever, 1997). Vicarious experiences
develop from observation of other people (Bandura, 1977). Self-efficacy increases by
seeing people similar to ourselves with a similar skill set to succeed at a given task
(Bandura, 1977; Bandura, 1982). Vicarious experiences increase self-efficacy by
modeling, not social comparison (Bandura, 1982). Information regarding the nature and
predictability of the environment may be conveyed by modeling (Bandura, 1982).
Effective strategies for dealing with situations may be taught by effective modeling
(Bandura, 1982). Induction of vicarious experiences self-efficacy includes live modeling
and symbolic modeling (Bandura, 1977).
Verbal persuasion. Influential people may strengthen a person’s belief that they
possess the skills and are capable of successfully accomplishing a task (Bandura, 1977;
Bandura, 1982). Self-efficacy arising from verbal persuasion is generally weaker than by
mastery experiences due to a lack of an authentic experiential base (Bandura, 1977).
Although verbal persuasion may not be as effective as mastery experiences in increasing
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self-efficacy, verbal persuasion does contribute to success when provided with
provisional aids (Bandura, 1977). Induction of verbal persuasion self-efficacy includes
suggestion, exhortation, self-instruction, interpretive treatments (Bandura, 1977).
Physiological states. Stressful and taxing situations increase emotional arousal,
which may enhance or impede the ability to successfully complete or cope with a task
(Bandura, 1977; Bandura, 1982). Individuals are more likely to expect success if they are
not overcome by the emotional arousal of the anticipated event (Bandura, 1977; Bandura,
1982). Induction of decreased physiological states self-efficacy, also known as
emotional arousal, includes attribution, relaxation, biofeedback, symbolic desensitization,
and symbolic exposure (Bandura, 1977).
The self-efficacy theory is a comprehensive theory which provides a conceptual
framework incorporating multiple modes of influence to affect behavior (Bandura, 1982).
The self-efficacy theory associates efficacy independent of performance to provide a
basis for predicting the generality of coping behavior (Bandura, 1977). Self-perceived
capabilities allow people to attempt to cope, and people will avoid stressful events if they
perceive the environment exceeds their ability (Bandura, 1982).
Implementation of Peer Mentor Quality Improvement Program
Setting
This project took place in the microsystem of an out-patient independently owned
dialysis center in Grand Forks, North Dakota (ND), following the recommendations of
Midwest Kidney Network (MKN). MKN serves as a governing body for dialysis centers
of five upper mid-western states (ESRD National Coordinating Center, 2018), including
ND. The peer mentor program was recommended by MKN to increase patient and
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family engagement (Bolgana, 2018). The Midwest Kidney Network’s goal was 50% of
the dialysis units within this network would have a peer support program in place by the
end of 2018 (Bolgana, 2018). The peer mentor program was aligned with the mission
statement of the dialysis unit to “provide the highest quality and up-to-date care to
dialysis patients while promoting optimal health and quality of life” (J. McGauvran,
personal communication, September 5, 2018). Aurora Dialysis is a free-standing,
privately owned facility and has no affiliation with a healthcare system.
Participants
Participants were currently receiving hemodialysis treatments at one
independently owned outpatient facility. Participants were age 18 or older men and
women. All races/ethnicities were included.
Participants were recruited by convenience sampling from Aurora Dialysis in
Grand Forks, North Dakota. The ability to access study participants included thriceweekly on-site treatments for hemodialysis patients. Participants were enrolled in the
study by self-identification or referral from direct dialysis staff, including nursing,
dietician, physician, and social work. A recruitment flyer was placed in the patient
waiting room, upon entrance to the dialysis unit in front of the patient scale, and one flyer
was given to each patient. The flyers were available for the dialysis staff, as well. The
interested patients were referred to the Principle Investigator (PI) as stated above.
Inclusion criteria


Mentor inclusion criteria: over 18 years of age, received hemodialysis
treatments for more than 12 months and reported access to cellphone or
telephone
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Mentee inclusion criteria: over 18 years of age, received at least one
hemodialysis treatment but less than 12 months of hemodialysis
treatments and reported access to cellphone or telephone



Comparison inclusion criteria: over 18 years of age, was not willing to
participate in the peer mentor group but willing to complete questionnaires

Exclusion criteria all groups


under 18 years of age, non-English speaking patients without an
interpreter, medical diagnosis of aphasia or severe dementia, reported no
access to cellphone or telephone

Possible risks to subjects. There were no anticipated injury or physical risks,
beyond those experienced in everyday life, for participating in this research study. Some
of the survey questions may have appeared personal, causing discomfort. The participant
was instructed to contact the PI if they wanted to discuss their feelings at 701-213-8813.
The other potential risk was the breach of confidential information. To avoid breach of
confidentiality, a random number was given to each participant for all communications;
the mentors and mentees were trained especially in this regard, and participants signed a
statement that they would not discuss the personal information of the mentor or mentee
with anyone else nor in the social media.
Confidentiality. A random number was given to each participant. The random
number was used on all documents. On a sheet of paper, the PI gathered the name and
phone number of the participants and the random number for future use. This sheet of
paper and consent forms was stored in a locked box in the PI’s office. A passwordprotected computer, which is locked in a cabinet in the PI’s office, was used to store all
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results. Results will be destroyed using shredder three years after data analysis is
complete. Data were reported in aggregate form using pseudonyms (study location,
names, etc.) in all reports.
Consent. Participants were informed of the study in person by the PI using the
“Informed Consent Statement.” Participation in this study was voluntary. The
participants received an explanation regarding the study’s purpose, time commitments,
and participation requirements including voluntary participation (see Appendix C).
Participating or declining to participate in this research did not affect the patient’s care.
The participant may have opted-out of this research at any time by verbal contact with the
PI. Consent was reaffirmed before each interaction/session with PI; consent was
reaffirmed by having the participants initial the corresponding line on the participant’s
original consent form.
Design. The overall design of this project was pre/post-intervention evaluation
quasi-experimental. Pre and post-intervention assessment tools are discussed in the
instrument section. The dialysis unit was broken into an intervention and a comparison
group. The intervention group participated in the peer mentor program with usual care,
while the comparison group received usual care. Participation in the peer mentor group
included mentors and mentees.
Intervention. The intervention included participation in the peer mentor program
plus usual care. The comparison included the usual care only.


Step 1: Adaptation of pre-designed peer mentor program from Quality
Insights Renal Network 5 (2018) Peer UP program. Adaptation of the
Peer UP peer mentor program was completed by the PI to meet the needs
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of the rural outpatient hemodialysis clinic in North Dakota. See Appendix
D for the permission email.


Step 2: Facility staff training: The PI trained facility staff including
management, nurse practitioners, physicians, nursing, Masters’ social
worker (MSW), and dietitians by 45-minute powerpoint presentation. See
Appendix E for staff training material.



Step 3: Participant recruitment. Flyers were distributed as described
above. Each participant expressing interest in the study (self or staff
identified) was directed to the PI. The PI met the potential participants in
person while they were in the facility for dialysis care. After introducing
the project, per the recruitment script (Appendix F), each participant was
given an informed consent statement (Appendix C). Participants
expressing interest in being a mentor or mentee were given a program
application, which included participants’ names, days of dialysis
treatments, type of dialysis access, and personal interests (Appendix G),
which was completed before participating in the study. Interaction
between the PI and potential study participants lasted 30 – 45 minutes for
each participant. The completed application was returned to the program
coordinator, the MSW, as she was present in the dialysis center each
weekday.



Step 4: Allocation of participants to groups by the PI was completed
following the inclusion and exclusion criteria described above.
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Step 5: Pre-intervention survey. Surveys were distributed by the PI during
a scheduled dialysis treatment. Each study participant received the same
paper surveys, including demographics, Kidney Disease Quality of Life
(KDQOL) short form – 36 (Rand Health, 2018), Self-efficacy for
Managing Chronic Disease (SEMDC) 6-item scale (Self-Management
Resource Center, 2018), and Patient Health Questionnaire (PHQ-9) 9 item
scale (Pfizer, 1999). All surveys were in paper format. The surveys
included the patient’s assigned random number instead of personal
identifiers to protect confidentiality. The surveys were completed during
the scheduled dialysis treatment. If the participant was unable to complete
the survey without assistance or requested assistance with the completion
of the survey, assistance was provided by the PI. Assistance to complete
the survey consisted of reading the survey questions to the participant.
Completion of the surveys lasted less than one hour for most of the
participants.



Step 6: Mentor and mentee matching. Matching was completed by the PI
using the program application. Priority matching question was item
number one which was days of dialysis treatments. Given the rural
geographic location of the hemodialysis facility and length of travel time
for some participants, it was important to match participants, so that they
may interact on off-dialysis days. Questions are listed in the application in
order of importance and matching occurred by order of the questions. See
Appendix G for matching questions from the program application. The

25

mentors and mentees were matched with similar interests. Mentors were
given the name and phone number of the mentee by the PI. This step took
four hours to complete.


Step 7: Training of participants by the PI. Mentor training included a
program overview and skills in active listening, motivating, self-care tips,
confidentiality, and seeking assistance from clinical staff. The mentor
training material was adapted from the Peer UP program (Quality Insights
Renal Network 5, 2018). Mentor training occurred during three
consecutive hemodialysis treatments and lasted 1 hour 45 minutes each
session. Mentee training occurred during one hemodialysis session and
included an overview of the program and confidentiality. Mentee training
lasted 30 minutes per participant.



Step 8: Intervention. Mentors initiated interactions with mentees by
cellphone or telephone following the mentor guide (Appendix H).
Interactions lasted approximately 30 – 120 minutes each time and
occurred bi-monthly for three months. Mentors and mentees completed a
contact log form with each interaction. The contact log forms were
returned to the PI during regularly scheduled dialysis treatments. See
Appendix I for mentor log and Appendix J for mentee log forms.



Step 9: Post-intervention survey. Surveys were distributed by the PI
during a scheduled dialysis treatment. Each study participant received the
same paper surveys, including Kidney Disease Quality of Life (KDQOL)
short form – 36 (Rand Health, 2018), Self-efficacy for Managing Chronic
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Disease (SEMDC) 6-item scale (Self-Management Resource Center,
2018), and Patient Health Questionnaire (PHQ-9) 9 item scale (Pfizer,
1999) The surveys included the patient’s assigned random number instead
of personal identifiers to protect confidentiality. The surveys were
completed during the scheduled dialysis treatment. If the participant was
unable to complete the survey without assistance or requested assistance
with the completion of the survey, the PI provided assistance by reading
the questions to the participant. Participants in the intervention group
(mentors and mentees) also received a program feedback form. The
feedback form did not request patient identifying information. The mentor
and mentee feedback forms were adapted from Quality Insights Renal
Network 5 (2018). See Appendix K for the mentor feedback survey and
Appendix L for the mentee feedback survey forms. Completion of the
surveys lasted less than one hour for most of the participants.


Step 10: Data Analysis. Data was analyzed using SPSS in an aggregate
form without patient identifying information by an independent
statistician. This step lasted one month.

Timeline. This project began after receiving the Institutional Review Board
(IRB) approval from the University of Alabama in Huntsville IRB on January 22, 2019.


Step 1: Adaptation of pre-designed peer mentor program – January 22 – 30, 2019



Step 2: Facility staff training – January 30, 2019



Step 3: Participant recruitment – February 1 – 14, 2019



Step 4: Allocation of participants to groups – February 14 – 18, 2019
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Step 5: Pre-intervention survey – February 18 – 19, 2019



Step 6: Mentor and mentee matching – February 20, 2019



Step 7: Training of intervention group participants
o Mentor training – February 25 - March 1, 2019
o Mentee training – March 1, 2019



Step 8: Intervention three months – March 4 – June 3, 2019



Step 9: Post-intervention surveys – June 3 – 6, 2019



Step 10: Data Analysis – July 2019
Cost. The total cost of this peer mentor program with evaluation was estimated at

$2405.00, which included 42-hours registered nurse (RN) and 30-hours MSW work
hours.
Data. Participant demographic data was collected as well as pre and postintervention survey data of all participants. Surveys were collected by the MSW. The
random number assigned to each participant was used on all documents to protect the
participant’s privacy and confidentiality. Data analysis was conducted using only
aggregate de-identified data to protect the participant’s privacy and confidentiality. A
password protected computer in the PI’s office was used to store all results. Results will
be stored for a minimum of three years after data analysis is complete, or for a period of
time which meets federal, state, local regulations, and organizational policies and
procedures.
Instruments
Self-efficacy for managing chronic disease (SEMCD). The SEMDC (SelfManagement Resource Center, 2018) survey is a six-item scale which developed from
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long-standing research in chronic disease management and self-efficacy (Freund,
Genishen, Goetz, Szecsenyi, & Mahier, 2013). This survey is reliable, valid, and
economic among different chronic disease states and has been widely tested (Freund et
al., 2013; Riehm et al., 2016; Ritter & Lorig, 2014). Emotional function, communication
with healthcare providers, symptom control, and role function are the primary domains of
SEMDC (Freund et al., 2013). SEMDC is available online and is free to use for noncommercial purposes (Self-Management Resource Center, 2018). Refer to Appendix M
for SEMCD (Self-Management Resource Center, 2018).
KDQOL-36. The KDQOL-36 (Rand Health, 2018) survey provides scores of
physical and mental composites (items 1 – 12), the burden of kidney disease (items 13 –
16), symptoms (items 17 – 28), and effects of kidney disease (items 29 – 36) (Rand
Health, 2018). The KDQOL-36 (Rand Health, 2018) is considered a reliable and valid
tool for measuring quality of life in dialysis patients (Fujisawa et al., 2000; KalantarZadeh, Kopple, Block, & Humphreys, 2001; Liem et al., 2007 Peipert, Bentler, Klicko, &
Hays, 2017). Scoring was completed with use of the KDQOL-36 Excel scoring tool
(Rand Health, 2018). Scores range from zero to 100 for each item, and better health is
indicated by a higher score (Liem, Bosch, Arends, Heijenbrok-Kal, & Myriam Hunick,
2007). All surveys developed by Rand Health (2018) are available online and are free for
non-commercial use. Refer to Appendix N for KDQOL-36 (Rand Health, 2018).
PHQ-9. The PHQ 9 is a nine-item survey which is considered a reliable and valid
multipurpose instrument for depression and rates the frequency of depression symptoms
(Pfizer, 1999). The survey is free for public use and, when used repeatedly, can reflect
improvement or worsening of depression symptoms (Kroenke, Spitzer, & Williams,
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2001). The score is calculated by adding the individual responses of the nine questions.
Data were analyzed for statistically significant changes from pre to post-survey within
each group and between the groups. Refer to Appendix O for PHQ-9 (Pfizer, 1999).
Evaluation of Objectives
Health Outcome Hypothesis
Quality of life. The application of a peer mentor program will increase the quality
of life scores in the intervention group.
Self-efficacy. The application of a peer mentor program will increase selfefficacy in the intervention group.
Depression symptoms. The application of a peer mentor program will decrease
depression symptoms in the intervention group.
Process Objectives
Number of participants. Six mentors, six mentees, and 11 comparison
participants completed the study.
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Section II
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DNP Project Product
I. Nephrology Nursing Journal
A. Scope of the journal.
The Nephrology Nursing Journal is a peer-reviewed journal designed to meet the
educational needs of nephrology nurses at all levels of practice.
B. Aim of the journal.
The aim of the journal is to disseminate current information in research, practice, and
education. Author guidelines are included in Appendix P.
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Lessons Learned: Implementation of Peer-to-Peer Mentor Program in Individuals
Requiring Hemodialysis
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Abstract
Individuals requiring dialysis experience significant life-style, emotional, and
physical changes that affect quality of life (QOL). The peer mentor program pairs an
individual with dialysis experience (mentor) with an individual new to dialysis (mentee)
to provide support by sharing lived experiences which have been associated with
improved health outcomes. The purpose of this paper is to describe the lessons learned
during the implementation and evaluation of a peer mentor program to identify
characteristics necessary for the success of peer-to-peer mentoring in a rural setting.
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Learning Outcome
After reading this manuscript, the learner will be able to describe three
recommendations when implementing a peer-to-peer mentor program in individuals
requiring outpatient hemodialysis.
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Lessons Learned: Implementation of Peer-to-Peer Mentor Program in Individuals
Requiring Hemodialysis
The development and progression of chronic kidney disease (CKD) is a
significant health concern. Currently, over 30 million Americans have CKD (CDC,
2015). The incident of kidney failure continues to rise with 124,000 new cases annually,
with 99% over the age of 22 years (United States Renal Data System [USRDS], 2017).
The prevalence of kidney failure rises 20,000 cases annually (USRDS, 2017). In the US,
with over 468,000 individuals (National Kidney Foundation, 2016), dialysis is the most
common type of kidney replacement therapy (USRDS, 2017). Individuals requiring
dialysis are older and have more comorbidities than years past which compounds the
health and financial issues surrounding kidney failure and dialysis (Gilpin & Nichols,
2010; Perry et al., 2005).
The increasing incidence and prevalence rates of dialysis pose unique issues to
nursing. This large patient population needs care, compassion, and education to selfmanage their chronic disease. Most individuals with kidney failure also have comorbid
chronic health conditions of hypertension and diabetes (USRDS, 2017). Many physical
and emotional life changes, including social and psychological challenges, accompany a
diagnosis of kidney failure with required dialysis or transplant (Morton, Tong, Howard,
Snelling, & Webster, 2010; Shell, Patel, Ammarell, & Steinhauser, 2012; Tong et al.,
2009). The use of available resources is necessary to promote positive health outcomes
in this population.
Identification of the Problem
The progression to kidney failure requiring dialysis may be overwhelming for
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patients and their carers. Dialysis is a life-changing treatment plan requiring changes in
lifestyle (Jankowska-Polanksa et al., 2016; Kaitelidou et al., 2005) and limits the ability
to be gainfully employed which significantly impacts the patient, patient’s family, and
society (Ghahramani, 2015). In addition to significant morbidity and mortality
(Ghahramani, 2015), dialysis often results in physical disability and depression
(Finkelstein & Finkelstein, 2000; Kimmel, Weihs, & Peterson, 1993; Theofilou, 2011).
Additional symptoms faced by patients on dialysis include decreased social relationships,
sleep disturbances, and anxiety (Jankowska-Polanska et al., 2016; Theofilou, 2011). The
symptoms experienced by individuals requiring dialysis result in an overall decreased
quality of life when compared to healthy individuals (Jankowska-Polanska et al., 2016).
The complex nature of chronic disease management requires support and input
from a variety of sources (Embuldeniya et al., 2013). Trained health care professionals,
such as nurses, often provide individuals requiring dialysis with information and
education on symptom management, which includes fluid intake, dietary restrictions, and
medication schedules (Bennett, St. Clair Russell, Atwal, Brown, & Schiller, 2018). This
education is often sophisticated and is delivered at a time of high anxiety for individuals
transitioning to dialysis (St. Clair Russell et al., 2017). Nurses, although trained health
care professionals, may not fully comprehend the challenges faced by individuals
requiring dialysis as they have not experienced these challenges personally (Tim, King, &
Bennett, 2007).
Reduction of Disease Burden
A reduction in the kidney disease burden is beneficial for both patients and health
care organizations. One goal of Healthy People 2020 is to decrease the incidence and
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prevalence of CKD and its complications (Office of Disease Prevention and Health
Promotion, 2016). Utilizing available resources to reduce complications and kidney
disease burden is essential to improving patient outcomes while providing safe and
quality care. Efforts to engage patients and their families within the resources of
healthcare systems has become an interest of national concern. Quality improvement
(QI) initiatives involving patient engagement, such as the peer mentor program, are
recommended by Centers for Medicare and Medicaid Services (CMS, 2018), Institute for
Healthcare Improvement (IHI, 2018), World Health Organization (WHO, 2018), and the
Midwest Kidney Network (2018). Peer mentoring in individuals requiring dialysis has
been shown to reduce disease burden and improve health outcomes (Bennett et al., 2018;
Collins, 2016; Feroze et al., 2010; Ghahramani, 2015; Parry & Watt-Watson, 2009; St.
Clair Russell, et al., 2017; Symister & Friend, 2003; Thong et al., 2007).
Peer Mentor Program
The peer mentor program pairs a patient who has previously experienced or is
currently experiencing ESRD and hemodialysis (mentor) with a dialysis patient (mentee)
to develop a personal relationship which provides emotional support and information on
common health-related issues (Dennis, 2003; Hughes, Wood, & Smith, 2009). Newly
diagnosed ESRD patients requiring hemodialysis and patients struggling to self-manage
their condition may benefit from peer support through a peer mentor program (Taylor,
Gutteridge, & Willis, 2016).
Strengths of the peer mentor program include health related benefits to both
mentor and mentee (Bennett et al., 2018; Collins, 2016) such as improved survival and
quality of life in dialysis patients (Thong et al., 2007). Weaknesses of the program
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include the amount of time and cost needed to train mentors, limited clinical research,
and some mentees reported increased anxiety while participating in the peer mentor
program (Hughes et al., 2009).
Key peer mentor program components have been identified to include assistance
in disease management skills, emotional and social support, linkage to clinical care, and
ongoing support (Boothrod & Fisher, 2010; Fisher et al., 2014). Disease management
skills and support may be included as components of mentor training. Linkage to clinical
care and ongoing support may be included as components of staff training. These key
peer mentor program components may be applied flexibly depending on the aim of the
program and needs of the healthcare system and population (Bennett et al., 2018;
Boothroyd & Fisher, 2010).
Purpose
The purpose of this paper is to describe the lessons learned during the
implementation and evaluation of a peer mentor program to identify characteristics
necessary for the success of peer-to-peer mentoring in a rural setting. For this reason, a
peer mentor program was implemented and evaluated in one independently owned outpatient hemodialysis facility in rural North Dakota. The question of interest for this
quality improvement project was, in outpatient adult patients requiring hemodialysis, how
will a peer mentor program affect the quality of life (QOL), depression symptoms, and
self-efficacy in program participants compared to non-program participants over three
months? The hypotheses included a positive impact on QOL, depression symptoms, and
self-efficacy in the peer mentor program participants.
Conceptual Framework
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The conceptual framework used to design this quality improvement project was
the self-efficacy theory. Bandura’s (1977) theory of self-efficacy indicates a person’s
self-belief in the competencies one possesses will increase or decrease the chance of
accomplishing a task. The ability to engage with one’s environment is more than
knowing what to do in a situation (Bandura, 1982). Efficacy with successful interactions
in the environment involves a mixture of behavior, social, and cognitive skills (Bandura,
1982).
People try to maintain control of their lives by controlling events. Perceived selfefficacy if a belief in one’s ability to adapt to changes in an environment that may be
ambiguous, unpredictable, and stressful (Bandura, 1986; Bandura, 1997). The theory of
self-efficacy is not indicated to measure a person’s adaptation skills but is intended to
measure a perceived belief of what a person thinks can be accomplished with the skill set
already possessed (Bandura, 1986). A person’s most profound fear is defenselessness or
total loss of control of their personal environment (Bandura, 1986).
The development of new skills and expansion of current skills generates human
stress (Wiedenfeld et al., 1990). Stress contributes to physical dysfunctions, such as
immunologic suppression, (Wiedenfeld et al., 1990) and decreases quality of life (Ames,
Jones, Howe, & Brantley, 2001). Perceived self-efficacy affects the directions and
magnitude of stress on the body by the process of coping (Wiedenfeld et al., 1990) which
involves the process of appraising one’s coping efficacy in the face of unremitting
stressors (Widenfeld et al., 1990). A person’s ability to cope with changing events and
social conditions may significantly affect feelings of futility, despondency, and anxiety
(Bandura, 1982). A person may give up if overwhelmed by these negative feelings
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(Bandura, 1982). Development of strong self-efficacy is needed to change feelings of
futility, despondency, depression, and anxiety (Bandura, 1982). A person with strongly
perceived self-efficacy is more likely to persist until they are successful in accomplishing
the task at hand and can overcome negative feelings (Bandura, 1982). Self-efficacy
provides the intrinsic motivation that may cultivate competence (Bandura & Schunk,
1981) which may lead to improved quality of life in dialysis patients.
Increasing perceived self-efficacy involves four sources of information: mastery
experiences, vicarious experiences, verbal persuasion, and physiological states (Bandura,
1977). These sources of information are incorporated in varying degrees to increase
self-efficacy and decrease stressors (Bandura, 1977).
Mastery Experiences
Mastery experiences are associated with the most robust increase in self-efficacy
(Bandura, Adams, & Bever, 1997). Repeated successful task completion increases
perceived self-efficacy while repeated failures lower perceived self-efficacy (Bandura,
1977; Bandura, 1982). High self-efficacy from successful personal experience mastery
reduces the negative impact of occasional failures (Bandura, 1977). Induction of mastery
experiences self-efficacy includes participant modeling, performance desensitization,
performance exposure, and self-instructed performance (Bandura, 1977).
Vicarious Experiences
Vicarious experiences are the second most powerful source of self-efficacy
(Bandura, Adams, & Bever, 1997). Vicarious experiences develop from observation of
other people (Bandura, 1977). Self-efficacy increases by seeing people similar to
ourselves with similar skill set to succeed at a given task (Bandura, 1977; Bandura,
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1982). Vicarious experiences increase self-efficacy by modeling, not social comparison
(Bandura, 1982). Information regarding the nature and predictability of the environment
may be conveyed by modeling (Bandura, 1982). Practical strategies for dealing with
situations may be taught by effective modeling (Bandura, 1982). Induction of vicarious
experiences self-efficacy includes live modeling and symbolic modeling (Bandura,
1977).
Verbal persuasion
Influential people may strengthen a person’s belief that they possess the skills and
are capable of accomplishing a task (Bandura, 1977; Bandura, 1982). Self-efficacy
arising from verbal persuasion is generally weaker than by mastery experiences due to a
lack of an authentic experiential base (Bandura, 1977). Although verbal persuasion may
not be as effective as mastery experiences in increasing self-efficacy, verbal persuasion
does contribute to success when provided with provisional aids (Bandura, 1977).
Induction of verbal persuasion self-efficacy includes suggestion, exhortation, selfinstruction, interpretive treatments (Bandura, 1977).
Physiological states
Stressful and taxing situations increase emotional arousal which may enhance or
impede the ability to complete or cope with a task (Bandura, 1977; Bandura, 1982).
Individuals are more likely to expect success if they are not overcome by the emotional
arousal of the anticipated event (Bandura, 1977; Bandura, 1982). Induction of decreased
physiological states self-efficacy, also known as emotional arousal, includes attribution,
relaxation, biofeedback, symbolic desensitization, and symbolic exposure (Bandura,
1977).
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The self-efficacy theory is a comprehensive theory which provides a conceptual
framework incorporating multiple modes of influence to affect behavior (Bandura, 1982).
The self-efficacy theory associates efficacy independent of performance to provide a
basis for predicting the generality of coping behavior (Bandura, 1977). Self-perceived
capabilities allow people to attempt to cope, and people will avoid stressful events if they
perceive the environment exceeds their ability (Bandura, 1982).
Methods
Design
The Institutional Review Board (IRB) from the University of Alabama in
Huntsville approved the project proposal on January 22, 2019. The peer mentor program
quality improvement project was a two-armed, mixed-method, pre/post-intervention
evaluation quasi-experimental design. The intervention group, consisting of mentors and
mentees, received the intervention plus usual care. The comparison group received usual
care only. The intervention site was one independently owned hemodialysis center in
rural North Dakota (ND). The hemodialysis center maintained a consistent 50 patient
census with all patients receiving thrice-weekly treatments and had no affiliation with a
healthcare system.
All participants received three paper surveys prior to the start of the intervention
and at the close of the intervention. Mentors and mentees also received one paper survey
for feedback on their experience with the peer mentor program. The surveys were
completed in the dialysis center during the participants' regularly scheduled hemodialysis
treatment. If a participant requested assistance to complete the surveys, assistance was
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provided by facility staff by reading the questions to the participant. Data was analyzed
for changes from pre to post-survey within each group and between the groups.
Instruments
Self-efficacy for managing chronic disease (SEMCD). The SEMCD (SelfManagement Resource Center, 2018) survey is a six-item scale which developed from
long-standing research in chronic disease management and self-efficacy (Freund,
Genishen, Goetz, Szecsenyi, & Mahier, 2013). This survey is reliable, valid, and
economic among different chronic disease states and has been widely tested (Freund et
al., 2013; Riehm et al., 2016; Ritter & Lorig, 2014). Emotional function, communication
with health care providers, symptom control, and role function are the primary domains
of SEMCD (Freund et al., 2013). SEMCD is available online and is free to use for noncommercial purposes (Self-Management Resource Center, 2018).
Kidney Disease Quality of Life-36 (KDQOL-36). The KDQOL-36 (Rand
Health, 2018) is considered a reliable and valid tool for measuring the quality of life in
dialysis patients (Fujisawa et al., 2000; Kalantar-Zadeh, Kopple, Block, & Humphreys,
2001; Liem et al., 2007 Peipert, Bentler, Klicko, & Hays, 2017). The 36 question survey
provides scores of physical and mental composites (items 1 – 12), burden of kidney
disease (items 13 – 16), symptoms (items 17 – 28), and effects of kidney disease (items
29 – 36) (Rand Health, 2018). Scoring is completed with use of the KDQOL-36 Excel
scoring tool (Rand Health, 2018). Scores range from zero to 100 for each item and better
health is indicated by a higher score (Liem, Bosch, Arends, Heijenbrok-Kal, & Myriam
Hunick, 2007). All surveys developed by Rand Health (2018) are available online and are
free for non-commercial use.
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Patient Health Questionnaire-9 (PHQ-9). The PHQ 9 is a nine-item survey
which is considered a reliable and valid multipurpose instrument for depression and rates
the frequency of depression symptoms (Pfizer, 1999). The survey is free for public use
and, when used repeatedly, may indicate improvement or worsening depression
symptoms (Kroenke, Spitzer, & Williams, 2001).
Feedback Survey.

The mentor and mentee feedback surveys were adapted with

permission from Quality Insights Renal Network 5 (2018). The feedback surveys have
been in use since 2015 by the Peer UP program (Quality Insights Renal Network 5,
2018). Peer mentor program material is available online and free to use or adapt with
proper citation and credit to Quality Insights Renal Network 5 (2018).
Method: Peer Mentor Quality Improvement Project
Participants. Participants were recruited by convenience sampling from one rural
hemodialysis clinic. Participants were enrolled in the study by self-identification or
referral from direct dialysis staff, including nursing, dietician, physician, and social work.
Recruitment flyers were placed in the patient waiting room, upon entrance to the dialysis
unit in front of the patient scale, and one flyer was given to each patient.
Inclusion criteria.


Mentor inclusion criteria: over 18 years of age, received hemodialysis
treatments for more than 12 months; and reported access to cellphone or
telephone



Mentee inclusion criteria: over 18 years of age, received at least one
hemodialysis treatment but less than 12 months of hemodialysis treatments;
and reported access to cellphone or telephone
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Comparison inclusion criteria: over 18 years of age, not willing to participate
in the peer mentor program but willing to complete questionnaires

Exclusion criteria for all groups. Under 18 years of age, non-English speaking
individuals without an interpreter, medical diagnosis of aphasia, or severe dementia (as
reported in electronic health record), reported no access to cellphone or telephone.
Intervention
The intervention included participation in the peer mentor program plus usual
care. The comparison included the usual care only. The intervention was conducted from
January 23 through June 4, 2019. It included peer mentor program adaptation, staff
training, mentor and mentee training, mentor and mentee interactions by phone call, and
follow-up feedback surveys.
Program adaptation. A pre-designed peer mentor program (Quality Insights
Renal Network 5, 2018) was adapted to meet the needs of the rural outpatient
hemodialysis clinic in North Dakota. The outpatient dialysis clinic is located in a ND
city with a population of 56,000 people and a 19.7% poverty rate (Data USA, 2017).
More than 50% of individuals drove one hour from their home to the dialysis clinic with
some individuals driving up to three hours one way to reach the clinic. For this reason,
the peer mentor program was designed for the mentor/mentee interactions to be
completed by phone call.
Health care team training. The interdisciplinary health care team training
occurred January 30, 2019, and consisted of a 45-minute powerpoint presentation to three
mangers, three nurse practitioners, two physicians, ten nurses, one Masters’ prepared
social worker (MSW), and one dietitian. The staff promoted the peer mentor program,
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referred potential individuals to participate in the peer mentor program as mentors or
mentees, and provided ongoing support for the program during the intervention period.
See Table 1 for health care team training topics.
Participant recruitment. Participant recruitment occurred from February 2 – 18,
2019. Flyers to promote the peer mentor program were distributed to each individual
requiring hemodialysis and posted throughout the dialysis unit. Each participant
expressing interest in the study (self or staff identified) was given a program application
that requested the participant’s name, days of dialysis treatments, type of dialysis access,
and personal interests. This program application was used to allocate participants into the
intervention (mentor or mentee) or comparison group following inclusion and exclusion
criteria as described above. The program application was also used to match mentors
with mentees.
Pre-intervention survey. The pre-intervention surveys were distributed on
February 18 – 19, 2019, during the scheduled dialysis treatment for each participant.
Each participant received the same paper surveys of KDQOL– 36 (Rand Health, 2018),
SEMCD (Self-Management Resource Center, 2018), and PHQ-9 (Pfizer, 1999). The
surveys included the patient’s assigned random number at the top of page one instead of
personal identifiers to protect confidentiality. The surveys were completed during their
scheduled dialysis treatment.
Mentor and mentee matching. Matching of mentors with mentee was
completed using the program application forms with priority given to the days of dialysis
treatments. Given the rural geographic location of the hemodialysis facility and length of
travel time for some participants, it was essential to match participants by dialysis
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treatment days, so they would be able to interact on off-dialysis days. Mentors and
mentees were also matched with similar interests.
Training of participants. The training of participants occurred on February 25 –
March 1, 2019. Mentor training was adapted from Quality Insights Renal Network 5
(2018) Mentor Manual and included a program overview and skills in active listening,
motivating, self-care tips, confidentiality, and seeking assistance from clinical staff. See
Table 2 for modules and training topics for mentors. Mentor training was broken into
three training sessions that lasted one hour 45 minutes each. Mentors were trained in
groups of four, which allowed for interaction among the participants. Mentee training
included an overview of the program, expectations, and review of confidentiality. Each
mentee was trained individually for 30 minutes. Mentors and mentees were required to
sign a statement of confidentiality during training. Training occurred during the
participant’s scheduled hemodialysis treatment sessions.
Mentor-mentee interactions. The mentor-mentee interactions occurred from
March 2, 2019 – June 2, 2019. Mentors initiated interactions with mentees by cellphone
or telephone. Interactions lasted approximately 30 – 120 minutes each time and occurred
in frequence from once a month to twice a month. Mentors and mentees completed a
contact log form with each interaction, which included date and length of interaction,
topics discussed, and unit referrals. The health care team provided ongoing support of
the program by following-up with mentors and mentees regarding the peer mentor
program during each scheduled hemodialysis treatment. The staff encouraged the mentor
to call the mentee if the mentor indicated no interaction had occurred with the mentee in
the past week.
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Post-intervention survey. Post-intervention surveys were distributed to all
participants on June 3 – 4, 2019, during a scheduled dialysis treatment. Each participant
received the same paper surveys, as described above. Participants in the intervention
group (mentors and mentees) also received a program feedback form.
Data Analysis. Participant demographic data were collected at the beginning of
the project. Data was analyzed using SPSS by a blind third-party statistician in an
aggregate form without patient identifying information in July 2019.
Results
Participants
Initially, eight mentors, eight mentees, and 15 comparison participants were
enrolled in the study. Six mentors, six mentees, and 11 comparison participants
completed the study. The reasons for attrition included medical complications (one
participant), lack of interest (one participant), relocation (one participant), death (two
participants), and refusal to complete the post-intervention surveys (two participants).
See Figure 1 for the peer mentor program attrition rates.
Demographics
Mentors. There were six mentors, all male, that participated (Table 3). The
average age was 60.50 (SD = 8.142) years old, with the minimum age being 53 and the
maximum age being 73 for an age range 20 years. The data trends showed that most
participants were married, had a high school education, were white, non-Hispanic, and
not employed. The average number of months on dialysis was 68.33 (SD = 31.040), with
a minimum of 34.00 months and a maximum of 105 months (Table 3).
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Mentees. There were six mentees that participated, and two (33.3%) were male
and four (66.7%) were female (Table 3). The average age was 62.5 (SD = 6.535) years
old, with the minimum age being 54 and the maximum age being 71 for an age range 17
years. The data trends showed that most participants were widowed or divorced, had a
college education, were white, non-Hispanic, and were equally employed or not
employed. The average number of months on dialysis was 6 (SD = 4.290) with a
minimum of 0 months and a maximum of 11 months (Table 3).
Comparison group (no intervention). There were 11 in the comparison group
that participated, and four (36.4%) were male, and seven (63.6%) were female (Table 3).
The average age was 70 (SD = 12.259) years old, with the minimum age being 52 and the
maximum age being 88 for an age range 36 years. The data trends showed that most
participants were widowed or married, had a high school or a college education, were
white, non-Hispanic, and were not employed. The average number of months on dialysis
was 53 (SD = 49.673) with a minimum of 10 months and a maximum of 167 months
(Table 3).
Self-Efficacy
Within group comparisons. SEMCD mentee and mentor scores are shown in
Figure 2. Using paired samples t-tests, there was no statistically significant mean
differences found for mentors (M = .50, t (5) = -.465, p = 0.667) or mentees (M = .36, t
(5) = -.256, p = 0.808).
Between-group comparisons. An ANOVA found no mean group differences
between mentors, mentees and the comparison group on the post-SEMCD (F (2, 20) =
2.460, p = 0.111)
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Depression Symptoms
Within group comparisons. PHQ-9 mentee and mentor scores are shown in
Figure 3. Using paired samples t-tests, there was no statistically significant mean
differences found for mentees (M = 2.28, t (5) = 1.533, p = 0.176) or mentors (M = .33, t
(5) = .395, p = 0.709).
Between group comparisons. An ANOVA found no mean group differences
between mentors, mentees and the comparison group on the post-PHQ-9 (F (2, 21) =
2.798, p = 0.084)
Quality of Life
Within groups comparison. KDQOL-36 scores shown in Table 4.
Improvements in KDQOL-36 scores shown for mentees in the areas of symptom/problem
list; effects of kidney disease; and mental health composites. Improvements in KDQOL36 scores for mentors in the areas of symptom/problem list and burden of kidney disease.
There were no improvements in KDQOL-36 scores for comparison group. Using paired
samples t-tests, there was no statistically significant mean differences found for mentors
on symptom/problem list (M = 1.39, t (5) = -.400, p = 0.705), effects of kidney disease
(M = 0.00, t (5) = 0.00, p = 1.00), burden of kidney disease (M = 4.16, t (5) = -4.21, p =
0.691), physical health composite (M = 1.42, t (5) = 3.98, p = 0.707), and mental health
composite (M = -.16, t (5) = -.038, p = 0.971). Again using paired samples t-tests, there
were no statistically significant mean differences found for mentees on symptom/problem
list (M = -2.08, t (5) = -.613, p = 0.567), effects of kidney disease (M = -7.29, t (5) = 1.581, p = 0.175), burden of kidney disease (M = 0.00, t (5) = 0.00, p = 1.00), physical
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health composite (M = .91, t (5) = .157, p = 0.882), and mental health composite (M = 3.46, t (5) = -1.694, p = 0.151).
Between groups comparison. An ANOVAs showed no statistically significant
mean group differences found for mentors, mentees or the comparison group on
symptom/problem list (F (2, 20) = 2.903, p = 0.078), effects of kidney disease (F (2, 20)
= 1.308, p = 0.293), burden of kidney disease (F (2, 20) = .190, p = 0.829), physical
health composite (F (2, 20) = .495, p = 0.617), and mental health composite (F (2, 20) =
532, p = 0.595).
Mentee and Mentor Feedback
Five mentees returned the feedback form indicting an 83.3% return rate. Mentee
feedback is depicted in Table 5. The majority of mentees (60% or higher) indicated
talking with their mentor was helpful; sharing their story was helpful; learned new
information from mentor; felt comfortable asking their mentor questions; mentor listened
carefully; would recommend other dialysis patients talk with a mentor; and it is important
to continue the peer mentor program at their facility.
Two mentors returned the feedback form for a 40% return rate. Mentor feedback
is shown in Table 6. 100% of mentors reported talking with their mentee was helpful;
working with mentee helped them feel better; mentor training sessions prepared them to
be a mentor, and it is essential to continue the peer mentor program at their facility.
Discussion
The peer mentor program began with eight mentor-mentee pairs and concluded
with six mentor-mentee pairs. Each mentor-mentee pair reported a minimum of one
phone interaction monthly with one mentor-mentee pair reporting phone interactions
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twice monthly. The mentor-mentee pairs met by phone for only three months, which
may have been as few as three phone calls.
The program was associated with improved PHQ-9 scores by five mentees and
four mentors; improved SEMCD scores by four mentees and three mentors; and
improved KDQOL-36 mean scores in the areas of symptom/problem list, effects of
kidney disease, and mental health composite for mentees and symptom/problem list and
burden of kidney disease for mentors. Although the data analysis revealed no statistical
significance in these areas, it is important to recognize and appreciate the clinical
significance of these improved scores. Improvement in self-efficacy, quality-of-life, and
depression symptoms may ultimately affect morbidity and mortality for that individual.
The results of this project are aligned with previous research. Peer mentoring in
individuals requiring dialysis has been shown to reduce disease burden and improve
health outcomes (Bennett et al., 2018; Collins, 2016; Feroze et al., 2010; Ghahramani,
2015; Parry & Watt-Watson, 2009; St. Clair Russell, et al., 2017; Symister & Friend,
2003; Thong, Kaptein, Krediet, Boeschoten, & Dekker, 2007). However, the small
sample size and limiting interactions to phone calls may have affected the lack of
statistical significance found by data analysis. Also, three months is a short period for
communication between the mentee and mentor. This may not have been enough support
to show statistically significant improvements.
Positive feedback from mentors and mentees indicated that the peer mentor
program was a success. The participants expressed satisfaction with the current program
as implemented. The positive feedback reported from both mentors and mentees is also
clinically significant. Five mentees returned the feedback form with overall positive
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feedback. See Table 5 for a breakdown of questions and response percentages. 80% of
the mentees reported it was important the peer mentor program continue at their facility.
Four mentees reported learning new information from their mentors, feeling better after
talking with their mentor, would recommend other patients on dialysis talk with a mentor,
and meeting with a mentor helped them take better care of themselves.
Mentor feedback showed 100% of respondents either “Strongly Agreed” or
“Agreed” with all questions on the questionnaire, except one patient indicated no new
information was learned from their mentee (Table 6). Mentor feedback also indicated
100% of mentors felt it was essential the peer mentor program continue at their facility.
This positive feedback from mentors and mentees provided clinical significance to
reducing disease burden, which is especially important for this chronic disease
population.
Limitations
Threats to internal validity included the possibility of maturation and selection
bias. Selection bias was limited by including a control group. However, selection bias
cannot be entirely ruled out due to the nature of participant recruitment. The mentor
group was 100% male, while the mentee and comparison groups were 66.7% and 63.3%,
respectively. All groups were predominately white, non-Hispanic, and not employed
which is representative of the dialysis unit overall.
The number of months on dialysis varied widely within and between the groups.
The project was implemented in one privately owned rural outpatient hemodialysis clinic,
which maintained a consistent census of 50 patients. The sample size of six mentors, six
mentees, and 11 comparison participants was small. The project only allowed for phone
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calls between mentors and mentees as private space was not available on site for face-toface interactions.
Lessons Learned: Important Issues to Consider for a Successful Program
Flexible Program Delivery
Although the dialysis center did not have a private space available for confidential
face-to-face mentor-mentee interactions, this is an important aspect to consider when
implementing a peer mentor program. Written feedback from three mentees, and one
mentor indicated interaction options “other than phone calls” would have been beneficial.
The method of program delivery must be flexible to meet the needs of the population;
however, consistent enough to promote positive patient outcomes (Fisher et al., 2014).
Offering a variety of meeting options increases the likelihood of meeting individual
patient personality preferences (Fisher et al., 2014). The most prevalent programs offer a
combination of face-to-face and telephone combination (Bennett et al., 2018). Face-toface meetings and telephone calls have been shown to eliminate distance barriers and
facilitate diverse methods of contact (Bennett et al., 2018). An initial face-to-face
meeting may provide immediate reassurance and support for the mentee, while ongoing
monthly telephone calls assist in the development of the mentor-mentee relationship
(Bennett et al., 2018). Providing a space that allows for confidential mentor-mentee
interactions in addition to phone calls is recommended.
The length of peer mentor programs should also be considered. Extended period
programs promote the development of strong personal relationships (Heisler, 2006; Perry
et al., 2005). Shorter programs, which do not have objectives to develop strong personal
relationships, offer targeted interactions with bidirectional sharing of experiences and
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support which has been shown to promote positive outcomes in individuals with kidney
disease (Taylor et al., 2016). Positive patient outcomes have been associated with peer
mentor programs lasting a minimum of eight weeks with mixed methods of program
delivery (Joseph, Griffin, Hall, & Sullivan, 2001; MacPherson, Joseph, & Sullivan, 2004;
St. Clair Russell, 2017; Sutton & Erlen, 2006). The recommendation is to include a
minimum of eight weeks for mentor-mentee interactions while offering a variety of
options for contact such as phone calls, face-to-face meetings, and group meetings.
Interdisciplinary Staff Support
Interdisciplinary staff training is necessary to provide support to the mentormentee team and for a successful program (Bennett et al., 2018; McCarthy, 2017). An
interdisciplinary program team provides oversight and support for the program
(Boothroyd & Fisher, 2010; Fisher et al., 2015; Fisher et al., 2014), provides mentor
backup to answer clinical questions as needed (Fisher et al., 2014), and recruiting
mentors/mentees (Bennett et al., 2018). The supportive staff promotes program success
and sustainability (Bennett et al., 2018).
Mentors and mentees were asked by interdisciplinary staff at each dialysis
treatment if they had spoken with the respective mentor/mentee. Reports from staff,
after inquiring with mentors as stated above, indicated mentors often forgot to call their
mentees. Repetitive inquiries from the interdisciplinary staff were needed to ensure at
least one monthly phone interaction took place between the mentors and mentees. The
recommendation is to adequately train staff to promote and support the peer mentor
program at every phase of implementation and to follow-up with the mentor-mentee pair
at every treatment to encourage at least once-a-week interactions. Additional
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recommendation is to utilize the advanced training of an MSW to perform the functions
of program coordinator, matching mentor with mentee, mentor training, and program
management (Brown, 2006).
Mentor Training
The mentor training is another essential aspect of a successful peer mentor
program. Comprehensive mentor training is necessary to prepare the mentor to facilitate
the support of a mentee without providing medical advice (Bennett et al., 2018). Key
components of mentor training should include communication skills training (Bennett et
al., 2018; Collins, 2016; Funnell, 2010; Perry et al., 2003; Radice, 1995), problem
solving (Bennett et al., 2018; Collins, 2016; Perry et al., 2003), confidentiality (Bennett et
al., 2018; Collins, 2016; Radice, 199), disease knowledge for self-management of
symptoms (Bennett et al., 2018; Boothroyd & Fisher, 2010; Fisher et al., 2015; Perry et
al., 2003; Radice, 1995), and methods of providing social and emotional support
(Boothroyd & Fisher, 2010; Collins, 2016; Fisher et al., 2015; Funnell, 2010). Additional
periodic follow-up mentor training sessions are recommended to include monthly
sessions during the intervention period and refresher mentor training when a mentor is
matched with a new mentee.
Conclusion
In an era of time and financial constraints, methods of increasing patient
engagement and self-management of chronic symptoms have many implications for
nursing practice. Peer support may reduce health disparities (Adams, Paasse, & Clinch,
2011; Fisher et al., 2015; Perry et al., 2005). Peer mentoring is designed to provide nonhierarchical support from a peer who is currently or has experienced the same disease
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process and treatments (Bennett et al., 2018). This support system has the potential to
cross-cultural barriers and reach the people in most need of help and support (Perry et al.,
2005).
Nurse understanding of peer support and the peer mentor program is important to
foster the program (Bennett et al., 2018). Nurses may be responsible for providing
oversight of the program mentor training. Nurses are needed to provide mentor support,
back-up of mentor information or questions, bridging the gap between patients and
clinicians, and recruiting mentors/mentees. Sustainability of the peer mentor program is
dependent on nursing understanding and support of the program (Bennett et al., 2018).
Policy implications become highlighted as the peer mentor program becomes
available world-wide (Fisher et al., 2015). Nursing has the potential to positively
influence policy to incorporate peer mentor programs as part of chronic disease
management. The policy which supports formal training programs to include community
health workers is necessary to train a large workforce to sustain and support peer mentor
programs (Fisher et al., 2015). These policy changes have already begun with
recommendations from the World Health Organization and the Global Health Workforce
Alliance (Global Health Workforce Alliance, 2010).
Once mentors are trained, the program is sustainable. New mentors may be
trained at any time depending on facility needs and patient desire. The program is fluid to
allow for changes in method of delivery based on personal patient preference. The
sustainability of the program increases if all mentors are first expected to participate as a
mentee. Having each mentor first participate as a mentee will maintain interest in the
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program and an influx of mentees/mentors. Support from nursing staff to promote and
refer mentees/mentors to the program is essential for sustainability.
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Table 1
Health Care Team Training Topics









Purpose of the quality improvement project
Project question and hypothesis
Overview of kidney disease
Review of hemodialysis unit values, mission, and goals
Overview of peer mentor program design for unit
Peer mentor program benefits are shown in literature
The necessity of interdisciplinary staff support of the peer mentor program
Overview of mentor training

(adapted from Quality Insights Renal Network 5, 2018)
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Table 2
Mentor Training Modules and Topics
Module 1: Introduction to training (1 hour 45 minutes)
 Ground rules for training
 Describe peer mentor program
 List characteristics of peer mentor
 Describe a mentor-mentee meeting
 Define self-care related to hemodialysis
 Describe hemodialysis unit-specific referral resources
Module 2: Mentor skills and techniques (1 hour 45 minutes)
 Demonstrate mentee-mentor greeting
 Describe professional boundaries
 Formulate open-ended questions
 Explain characteristics of effective listening
 Demonstrate positive feedback such as praise and encouragement
 List skills necessary for positive and productive conversations
Module 3: Practice in pairs (1 hour 45 minutes)
 Demonstrate mentoring skills
o Active listening
o Reframing
o Motivation
o Self-care tips
o Confidentiality
o Seeking assistance from others and unit specific resources
 Receive certificate of training completion
(adapted from Quality Insights Renal Network 5, 2018)
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Table 3
Demographics of Participants
Mentor count (%)
n=6

Mentee count (%)
n=6

Comparison count (%)
n = 11

Gender
 Male
 Female

6
0

(100)
(0)

2
4

(33.3)
(66.7)

4
7

(36.4)
(63.3)

Marital Status
 Single
 Married
 Divorced
 Widowed

0
4
2
0

(0)
(66.7)
(33.3)
(0)

1
1
2
2

(16.7)
(16.7)
(33.3)
(33.3)

1
5
1
4

(9.1)
(45.5)
(9.1)
(36.4)

Education Level
 Some high school
 High school
 College

0
4
2

(0)
(66.7)
(33.3)

1
2
3

(16.7)
(33.3)
(50)

5
0
6

(45.5)
(0)
(54.5)

Race




6
0
0

(100)
(0)
(0)

5
1
0

(83.3)
(16.7)
(0)

10
0
1

(90.9)
(0)
(9.1)

Ethnicity
 Non-Hispanic
 Hispanic

6
0

(100)
(0)

5
1

(83.3)
(16.7)

11
0

(100)
(0)

Employment
 Employed
 Not employed

1
5

(16.7)
(83.3)

3
3

(50)
(50)

1
10

(9.1)
(90.9)

Months on dialysis
 Minimum
 Maximum
 Average

34
105
68.33

White
Hispanic
American Indian

0
11
6
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10
167
53

Table 4
KDQOL-36 Scores and Results

Scale

Pre-mean Post-mean Pre-mean
Mentee
Mentee
Mentor
Symptom/problem 71.18
73.26
90.28
list
Effects of kidney
65.10
72.40
85.42
disease
Burden of kidney 50.00
50.00
55.21
disease
Physical health
33.09
32.18
39.37
composite
Mental health
53.60
57.06
55.68
composite

Post-mean Pre-mean
Mentor
Comparison
91.67
82.39

Post-mean
Comparison
80.68

85.42

85.23

84.09

59.38

71.02

59.09

37.96

37.98

36.3

55.85

54.93

52.55

Note. Paired samples t-tests mentors: No statistically significant mean differences
found for mentors on symptom/problem list (p = 0.705), effects of kidney disease (p =
1.00), burden of kidney disease (p = 0.691), physical health composite (p = 0.707), and
mental health composite (p = 0.971).
Paired samples t-test mentees: No statistically significant mean differences found for
mentees on symptom/problem list (p = 0.567), effects of kidney disease (p = 0.175),
burden of kidney disease (M = 0.00, t (5) = 0.00, p = 1.00), physical health composite (p
= 0.882), and mental health composite (p = 0.151).
ANOVA between group comparison: No statistically significant mean group
differences found for mentors, mentees or the comparison group on symptom/problem
list (p = 0.078), effects of kidney disease (p = 0.293), burden of kidney disease (p =
0.829), physical health composite (F (2, 20) = .495, p = 0.617), and mental health
composite (p = 0.595).
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Table 5
Mentee Feedback (n = 5)

Question

Strongly Agree
Agree
n (%)
n (%)

The talks I had with my
mentor were helpful to me.
Talking more with my mentor
would have been helpful to
me.
My mentor sharing his or her
story was helpful to me.
Meeting with my mentor made
it easier to cope with my
kidney disease.
I learned new information
from my mentor.
I felt comfortable talking to
my mentor.
I felt comfortable asking my
mentor questions.
I felt better after talking with
my mentor.
My mentor listened carefully
to me.
I would recommend other
dialysis patients talk with a
mentor like mine.
Meeting with my mentor has
helped me take better care of
myself.
It is important the Peer Mentor
program continue at your
facility.

3 (60)

2 (40)

1 (20)

1 (20)

3 (60)

3 (60)

1 (20)

1 (20)

2 (40)

1 (20)

2 (40)

1 (20)

3 (60)

2 (40)

3 (60)

3 (60)

2 (40)

2 (40)

2 (40)

2 (40)

3 (60)

3 (60)

1 (20)

3 (60)

1 (20)

4 (80)

1 (20)
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Neither
Agree
nor
Disagree
n (%)

Disagree Strongly
n (%)
Disagree
n (%)

1 (20)

1 (20)

1 (20)

1 (20)

Table 6
Mentor Feedback (n = 2)
Question

Strongly Agree
Agree
n (%)
n (%)

The talks I had with my
mentee were helpful to me.
Working with my mentee
helped me feel better.
Sharing my story was helpful
to me.
Meeting with my mentee made
it easier to cope with my
kidney disease.
I learned new information
from my mentee.
Serving as a role model to my
mentee made me take better
care of myself.
The mentor training sessions
prepared me to be a mentor.
I have use what I learned in the
mentor training sessions to
take care of myself.
It is important the Peer Mentor
program continue at your
facility.

2 (100)

Neither
Agree
nor
Disagree
n (%)

2 (100)
1 (50)

1 (50)

1 (50)

1 (50)

1 (50)
1 (50)

1 (50)
1 (50)

2 (100)
1 (50)

1 (50)

2 (100)
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Disagree Strongly
n (%)
Disagree
n (%)

Figure 1

Peer Mentor Program Attrition Rates
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Figure 2
SEMCD Scores
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Figure 3
PHQ-9 Scores Mentees and Mentors
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Appendix A

January 22nd 2019
Carey Haugen
Department of Nursing
University of Alabama in Huntsville
Dear Mrs. Haugen,

The UAH Institutional Review Board of Human Subjects Committee has
reviewed your proposal, Peer Mentoring: Improving Health Outcomes in Dialysis
Patients, and found it meets the necessary criteria for approval. Your proposal seems to
be in compliance with the institutions Federal Wide Assurance (FWA) 00019998 and the
DHHS Regulations for the Protection of Human Subjects (45 CFR 46).
Please note that this approval is good for one year from the date on this letter. If
data collection continues past this period, you are responsible for processing a renewal
application a minimum of 60 days prior to the expiration date.
No changes are to be made to the approved protocol without prior review and
approval from the UAH IRB. All changes (e.g. a change in procedure, number of
subjects, personnel, study locations, new recruitment materials, study instruments, etc)
must be prospectively reviewed and approved by the IRB before they are implemented.
You should report any unanticipated problems involving risks to the participants or others
to the IRB Chair.
If you have any questions regarding the IRB’s decision, please contact me.

Sincerely,

Bruce Stallsmith
IRB Chair
Professor, Biological Sciences
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Appendix B
Facility Approval Letter
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Appendix C
Informed Consent Statement
The Self-Efficacy for managing Chronic Disease and Kidney Disease Quality of Life
surveys are completed on paper or computer and do not ask for identifying information.
These surveys are anonymous. If you request assistance in completing the survey, your
survey will be confidential. All identifying information will be removed and data will be
analyzed in aggregate form. All survey responses and aggregate assessment scores will
be kept confidential and stored on a secure server. The Principle Investigator is unable to
guarantee the security of your computer or responses if completing the survey out of the
facility. If results from this research are published, no information that would identify
you will be included.
Right to Ask Questions:
The Principle Investigator for this research study is Carey Haugen, MS, RN, AGCNSBC. You may ask any questions you have regarding the study at this time or at a later
date in person or by phone at 701-213-8813.
Please contact The University of Alabama in Huntsville Institutional Review Board at
256-824-6992 if you have questions regarding your rights as a research subject,
problems, complaints, or concerns about the research. You may call this number if the
Principle Investigator is unable to be reached or you wish to talk to an individual who is
not a member of the research team. The Institutional Review Board website contains
general information regarding research subjects and may be found at
https://www.uah.edu/irb.
Voluntary Participation:
Your participation in this research study is voluntary. You do not have to participate in
this study and you may cancel your participation at any time. Participating or not
participating in this research study will in no way affect your care at the dialysis center.
You do not have to answer any questions you do not wish to answer.
You must be 18 years of age or older to consent to participate in this research study.
You may contact the Principle Investigator either in writing or verbally to decline or
cancel your participation in this study.
Please keep this form for your records or future reference.
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Appendix D
Permission Email
Permission Statement:
From: Vinson, Brandy [mailto:BVinson@nw5.esrd.net]
Sent: Wednesday, September 26, 2018 11:01 AM
To: Haugen, Carey <carey.haugen@und.edu>
Cc: Cecil, Heather <HCecil@nw5.esrd.net>
Subject: RE: Peer UP Program Resources
Thank you for your interest in our PeerUp program. Please use our resources as you see
fit and adapt as needed, we only request that you state that the materials were adapted
from Quality Insights Renal Network 5.
If you have additional questions please let me know. Good luck!
Brandy

Brandy Vinson| Executive Director
804.320.0004 | ext. 2711 | www.esrdnet5.org
Bringing People and Information Together to Improve Health

From: Haugen, Carey [mailto:carey.haugen@und.edu]
Sent: Wednesday, September 26, 2018 10:42 AM
To: ESRD-NW5-Generic
Subject: Peer UP Program Resources

Good Morning,
I am a Doctor of Nursing Practice (DNP) student working with Aurora Dialysis in Renal
Network 11 and we would like to start a peer mentor program for our dialysis patients. In
doing research for this project, I have read the Peer UP information and resources
available on the website. Are these resources copy-righted in any way? We are
interested in using the information provided on the website for our mentor training,
however, I wanted to check with Renal Network 5/Peer UP Program to determine if these
resources may be modified to fit our program without special permission. Thank you for
your time.

Carey Haugen, MS, RN, AGCNS-BC
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Appendix E
Staff Training Material
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Appendix E
Staff Training Material
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Appendix E
Staff Training Material
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Appendix F
Recruitment Script
You are invited to participate in a research study about peer mentoring. This study is designed to
help us to better understand peer mentoring on dialysis patient’s self-efficacy, quality of life, and
symptoms of depression. The study will match a mentor with a mentee. The mentor should be a
person with dialysis experience and who feels well-adjusted to the demands of kidney disease. A
mentee is usually a person new to dialysis or having difficulty adjusting to kidney disease.
Are you interested in being a mentor or a mentee?
Mentors: We are very happy you are interested in being a mentor! As a mentor, you will
provide social support and guidance without providing medical advice to a mentee. The program
requires a minimum of twice monthly interactions with your mentee, by phone for four months.
We will be conducting training on [INSERT DATE] to prepare you to be a mentor. In addition to
a fun, interactive training by our staff where you’ll learn more about dialysis and how to mentor
others, you will also get to speak with and learn from other dialysis patients who will also be
mentors. If you are still interested, I have an informed consent statement for you to read about
the study and an application for the peer mentor program for you to fill out. Please return the
application form to Mary Ann in Social Work by the end of the week.
Mentees: We are very happy you are interested in being a mentee. As a mentee, you will be
matched with a mentor based on similarities. The mentor will have special training in mentoring
and providing social support to help you take care of yourself while you are receiving dialysis
treatments. The program requires a minimum of twice monthly interactions with your mentor by
phone for four months. If you are still interested, I have an informed consent statement for you
to read about the study and an application for the peer mentor program for you to fill out. Please
return the application form to Mary Ann in Social Work by the end of the week.
Not a mentor or a mentee: We would still like you to participate in the study. If you are still
interested in being part of the study, but not part of the peer mentor program, I have an informed
consent statement for you to read about the study.
Participation in the research study is voluntary and refusal to participate will not change the
process or quality of your care. We look forward to working with you over the next four months
of the peer mentor program and know that you will find the experience to be informative and
rewarding. If you have any questions, please contact me at 701-213-8813.
(Adapted from Quality Insights Renal Network 5, 2018)

87

Appendix G
Peer Mentor Program Application

hank you for your interest in the Peer Mentor program. Please answer the questions
on this application as best as you can. This will help us pair you with another
participant. Please note that your answers will be kept confidential in accordance
with HIPAA laws.

Name:

Phone:

1. What days do you have dialysis treatments?
 Monday, Wednesday, Friday

 Tuesday, Thursday, Saturday

2. Do you have a Catheter for dialysis treatments?  Yes

 No

3. Do you have children or grandchildren at home?  Yes

 No

4. Do you have pets?  Yes

 No

5. Who prepares your meals? (Check all that apply)
 Myself

 Family

 Caretaker  Other

__________________________________
6. Please list your interests, hobbies, commitments, activities, and any other information you
feel will help us pair you with another patient:
7. Are you interested in being a:  Mentee  Mentor
(Adapted from Quality Insights Renal Network 5, 2018)
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Appendix H
Mentor Guide
Mentors should
 Meet with mentees at least twice a month, either face-to-face or over the telephone
 Listen and show support
 Share tips and experience
SAMPLE PEER TIME
Greetings and welcome
Thank the mentee for making time to join you and caring about his or her health.
Ask about self-care in past week
 Fluids
 Diet
 Medications
 Attending all dialysis treatments
 Staying for the full treatment time
Point out and congratulate good self-care
 ASK: “What has gone well since we talked?”
Check in about expectations
 ASK: “How can I help you?”
Talk about one concern or challenge and how to address it
 ASK: “What makes it hard for you to do that?”
Remember: Share tips from your experience
BE A GOOD LISTENER
 Remember your body language
 Look at your mentee’s face
 Make eye contact
 Nod your head when you can relate or feel you understand what they are saying
GET HELP
 Go to the charge nurse right away if your mentee:
 Has questions about lab tests, medications, or other medical issues
 Seems unwell, sick, or unkempt
 Has problems with his or her vascular access
Ask open-ended questions
Show you are listening
 Repeat
 Rephrase in your own words
 Ask for more details
Remind the mentee that small steps
If the conversation becomes difficult
 Point out feelings
 Find the positive

can make a big difference! Think
of some small steps together.
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Appendix H
Mentor Guide



Change the topic
Take a break and find another time to talk

DON’T give medical advice or wrong information
 If you are unsure ask a charge nurse.
Keep discussions private
 Explain confidentiality to your mentee
 DON’T talk about your mentee with other patients, friends, or relatives
MOTIVATE AND BUILD CONFIDENCE
 Discuss reasons for good self-care
 To feel better
 For spouse or family
 To enjoy hobbies or interests
 For other things he or she cares about
 Talk about how you stay confident and motivated to take care of yourself
 Offer support and encourage the mentee to check in with his or her health care team with
questions
DON’T share or ask about
 Family or personal matters
 Finances or employment

Help the mentee pick something to work on
 Plan ahead for one change
 Try one small step from diet or fluid plan
 Repeat a past success
 Talk with a supportive friend or relative
 Review information on a topic of interest (offer your mentee material available at the
facility)
STAY PROFESSIONAL
DO
 Share your experiences with staying in treatment, managing fluids, eating certain foods,
taking your medications, and asking for help
Schedule a follow-up time to talk by phone or in person.
(Adapted from Quality Insights Renal Network 5, 2018)
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Appendix I
Mentor Log
Mentor name:

________

Mentee name:

Date:

What was the length of your interaction?
How did you and your mentee meet?
 By telephone
 Other
What did you and your mentee talk about?
 Fluid control
 Dietary restrictions
 Medications
 Vascular access
 Hospitalization
 Attending treatments as scheduled
 Staying for full treatments
 General dialysis information
 Other _____________________________________________________________
What materials did you use?
 Information provided by the Peer Mentor program
 Other information from facility
 Other _____________________________________________________________
Did you suggest your mentee talk with anyone?
YES
NO
If yes, with whom?
 Charge nurse
 Dietitian
 Nurse/Technician
 Social Work
 Nephrologist
 Other _____________________________________________________________
Did you talk to anyone about your peer mentor time? YES
NO
If yes, with whom?
 Charge nurse
 Dietitian
 Nurse/Technician
 Social Work
 Nephrologist
 Other _____________________________________________________________
When will you and your mentee meet again?__________________________________
(Adapted from Quality Insights Renal Network 5, 2018)
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Appendix J
Mentee Log
Mentor name:

________

Mentee name:

Date:

What was the length of your interaction?
How did you and your mentee meet?
 By telephone
 Other
What did you and your mentee talk about?
 Fluid control
 Dietary restrictions
 Medications
 Vascular access
 Hospitalization
 Attending treatments as scheduled
 Staying for full treatments
 General dialysis information
 Other _____________________________________________________________
Did your mentor suggest you talk with anyone?
YES
NO
If yes, with whom?
 Charge nurse
 Dietitian
 Nurse/Technician
 Social Work
 Nephrologist
 Other _____________________________________________________________
Did you talk to anyone about your peer mentor time? YES
NO
If yes, with whom?
 Charge nurse
 Dietitian
 Nurse/Technician
 Social Work
 Nephrologist
 Other _____________________________________________________________
When will you and your mentor meet again?__________________________________
(Adapted from Quality Insights Renal Network 5, 2018)
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Appendix K
Mentor Feedback Form

Overall, how would you rate your experience with your mentee?
□ Excellent
□ Very Good
□ Good
□ Fair
□ Poor
Please circle the number that matches how much you agree or disagree with
each of the following statements.
Strongly
Neither
Strongly
Agree
Agree Agree nor Disagree Disagree
Disagree
The talks I had with my
5
4
3
2
1
mentee were helpful to me.
Working with my mentee
5
4
3
2
1
helped me feel better.
Sharing my story was
5
4
3
2
1
helpful to me.
Meeting with my mentee
5
4
3
2
1
made it easier to cope with
my kidney disease.
I learned new information
from my mentee.
Serving as a role model to
my mentee made me take
better care of myself.
I helped my mentee learn
to take better care of
himself or herself.
The mentor training
sessions prepared me to be
a mentor.
I have used what I learned
in the mentor training
sessions to take care of
myself.
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Did talking with your mentee encourage you to think about other treatments
for kidney failure?
□ Yes
□ No
If yes, what other treatments have you thought about?
□ Transplant
□ Home hemodialysis
□ Peritoneal dialysis
□ Other: __________________________________
What did you like most about meeting with your mentee?
What did you like least about meeting with your mentee?
Please list at least one thing you learned from your mentee that you have used
to take care of yourself.
How likely is it that you will continue to meet with your mentee?
□ Extremely likely
□ Likely
□ Neither unlikely or likely
□ Unlikely
□ Extremely unlikely
On a scale of 1 to 7, with 1 being not at all important and 7 being extremely
important, how important is it to you that the Peer Mentor program continue
at your facility?
1

2

3

4

5

6

7

What other suggestions or thoughts do you have about your experience?
(Adapted from Quality Insights Renal Network 5, 2018)
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Appendix L
Mentee Feedback Form

Overall, how would you rate your experience with your mentee?
□ Excellent
□ Very Good
□ Good
□ Fair
□ Poor
Please circle the number that matches how much you agree or disagree with
each of the following statements.
Strongly
Neither
Strongly
Agree
Agree Agree nor Disagree Disagree
Disagree
The talks I had with my
5
4
3
2
1
mentor were helpful to me.
Talking more with my
5
4
3
2
1
mentor would have been
helpful to me.
My mentor sharing his or
5
4
3
2
1
her story was helpful to me.
Meeting with my mentor
5
4
3
2
1
made it easier to cope with
my kidney disease.
I learned new information
5
4
3
2
1
from my mentor.
I felt comfortable talking to
5
4
3
2
1
my mentor.
I felt comfortable asking
5
4
3
2
1
my mentor questions.
I felt better after talking
5
4
3
2
1
with my mentor.
My mentor listened
5
4
3
2
1
carefully to me.
My mentor was available to
5
4
3
2
1
me.
I would recommend other
5
4
3
2
1
dialysis patients talk with a
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mentor like mine.
Meeting with my mentor
5
4
3
2
1
has helped me take better
care of myself.
Did talking with your mentee encourage you to think about other treatments
for kidney failure?
□ Yes
□ No
If yes, what other treatments have you thought about?
□ Transplant
□ Home hemodialysis
□ Peritoneal dialysis
□ Other: __________________________________
What did you like most about meeting with your mentee?
What did you like least about meeting with your mentee?
Please list at least one thing you learned from your mentee that you have used
to take care of yourself.
How likely is it that you will continue to meet with your mentee?
□ Extremely likely
□ Likely
□ Neither unlikely or likely
□ Unlikely
□ Extremely unlikely
On a scale of 1 to 7, with 1 being not at all important and 7 being extremely
important, how important is it to you that the Peer Mentor program continue
at your facility?
1

2

3

4

5

6

7

What other suggestions or thoughts do you have about your experience?
(Adapted from Quality Insights Renal Network 5, 2018)
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Appendix M
Self-Efficacy for Managing Chronic Disease 6-Item Scale
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Appendix M
Self-Efficacy for Managing Chronic Disease 6-Item Scale
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Appendix N
Kidney Disease Quality of Life – 36
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Appendix N
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105

Appendix N
Kidney Disease Quality of Life – 36

106

Appendix O

107

Appendix Pappe
Author Guidelines Nephrology Nursing Journal
The Nephrology Nursing Journal (NNJ) is the official publication of the American Nephrology
Nurses Association (ANNA). The NNJ is a refereed clinical and scientific publication that
provides current information on a wide variety of subjects to facilitate the practice of
professional nephrology nursing. Its purpose is to disseminate information on the latest advances
in research, practice, and education to nephrology nurses and to positively influence the quality
of care provided.
The NNJ welcomes both solicited and unsolicited manuscripts and suggestions for
articles. Manu script queries should be submitted to bethtulrich@gmail.com. All materials must
be original and submitted for the exclusive use of the NNJ.
Complete author guidelines can be found at the ANNA website,
www.annanurse.org/journal. What follows is a summary of the NNJ guidelines.
Manuscript Preparation
All manuscript contents should adhere to the guidelines established by the Publication Manual of
the American Psychological Association (APA), 6th edition.
Technical Format. Manuscripts should be submitted using MS Word, in a 12-point font,
double-spaced, and one-inch (1”) margins. Preferred font is Times New Roman. Body text
should be indented at the beginning of each paragraph. A running header (shortened title) and
page number should be included at the top of each page of the manuscript except for the title
page. Length of submitted manuscripts varies with content. Manu scripts should be submitted as
one file (i.e., Title Page, Author Information, Abstract, etc.) unless separate files are absolutely
necessary. Reference software programs (including MS Word standard programming) should
NOT be used.
Headings. NNJ uses three levels of headings in the body of the manuscript:
First Level (bold, left-justified, underlined, Arial font)
Second Level (bold, left-justified, Times New Roman font)
Third level. (bold, at the start of the paragraph, Times New Roman font)
Author information and biographical statement. Include the author(s) name(s) on a
separate page, indicating primary author, and the contact address, telephone number(s), and
email address for the primary author. Include a 2-sentence autobiographical statement for each
author describing current employment, credentials, and (if applicable)ANNA chapter and ANNA
positions.
Disclosure statement. Include a statement signed by all authors that the contents, in
whole or in part, have not been previously reported, and are not under consideration for
publication elsewhere, nor will be, until a decision is made by the NNJ Editor.
Abstract. Include a complete succinct abstract of 75-125 words for all manuscripts.
References and Citations
References and citations must conform with the Publication Manual of the APA, 6th ed. (2010).
All citations in the text should be cited by author and date (for example, Doe & Brown, 2010).
List references in alphabetical order. Only include references that are actually cited within the
text. Authors are encouraged to provide the digital object identifier (DOI) number for all
references when possible.
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Citing multiple authors. In-text citations with six or more authors should include the
first author followed by et al., even in the first citation.
Reference List. If there are seven authors or less, list all authors. If there are eight
authors or more, list the first six, an ellipsis (…), and the last author. Sample:
Journal Article:
Author, A.A., Author, B.B., Author, C.C., Author, D.D., Author, E.E., Author, F.F., … Author,
Z.Z. (2012). Title of article. Journal Name, 10(2), 101-110.
Book Chapter:
Author, A.A., & Author, B.B. (2012). Title of chapter. In A. Editor & B. Editor (Eds.), Title of
book (pp. xxxxxx). Location: Publisher.
Photographs
Photographs should be submitted electronically and with a resolution at least 300 dpi or a
minimum of 1280 x 960 pixels.
Tables and Figures
Tables and figures must be of high quality contrast and include the data needed for the
table or figure to be adapted for publication. Provide detailed legends at the top of each table or
figure. If the table or figure is taken from another source, include a full reference citation.
Obtaining permission to reprint another's work is the responsibility of the author.
Copyright
All material published in the NNJ is protected by copyright. The NNJ does not accept
responsibility for statements or claims made by contributors. All authors are required to sign
a copyright release form and a disclosure of conflict statement.
Review Process
Generally (except for focus issues), manuscripts are sent for blind review to members of
the Manuscript Review Panel and/or the Editorial Board, with the Editor having the final
decision about disposition of manuscripts. Decisions are based on reviewer recommendations
on relevance to the NNJ readership, originality, educational value, strength of conclusions
(where applicable), clarity, and conciseness of literary expression. All editorial corrections,
clarifications, and additions re quested in the review process are the responsibility of the
author.
Submission Requirements
Authors should email manuscripts to nephrologynursing@ajj.com. Authors will receive
an acknowledgment within 14 days. Hard copies are no longer required.
For questions, contact: Editorial Coordinator
Nephrology Nursing Journal
East Holly Ave/Box 56
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